Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
70
CARE Quote, Financials, Valuation and Earnings
Last price:
$18.21
Seasonality move
:
0.51%
Day range:
$17.63 - $18.04
52-week range:
$13.61 - $20.40
Dividend yield:
0%
P/E ratio:
14.94x
P/S ratio:
3.02x
P/B ratio:
1.03x
Volume:
70K
Avg. volume:
103K
1-year change:
7.43%
Market cap:
$415.2M
Revenue:
$132.4M
EPS (TTM):
$1.20
Analysts' Opinion
-
Consensus RatingCarter Bankshares has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $21.33, Carter Bankshares has an estimated upside of 18.98% from its current price of $17.93.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $21.00 representing 100% downside risk from its current price of $17.93.
Fair Value
-
According to the consensus of 2 analysts, Carter Bankshares has 18.98% upside to fair value with a price target of $21.33 per share.
CARE vs. S&P 500
-
Over the past 5 trading days, Carter Bankshares has underperformed the S&P 500 by -1.06% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Carter Bankshares does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Carter Bankshares has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Carter Bankshares reported revenues of $36M.
Earnings Growth
-
Carter Bankshares has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Carter Bankshares reported earnings per share of $0.39.
Enterprise value:
-300.4M
EV / Invested capital:
--
Price / LTM sales:
3.02x
EV / EBIT:
-2.11x
EV / Revenue:
-2.21x
PEG ratio (5yr expected):
0.14x
EV / Free cash flow:
-17.33x
Price / Operating cash flow:
23.64x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.6%
Net Income Margin (TTM):
20.38%
Return On Equity:
7.29%
Return On Invested Capital:
5.2%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $171.4M | $125.4M | $135.7M | $32.7M | $36M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $2.35 | $0.57 | $1.20 | $0.25 | $0.39 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $999.2M | $1.1B | $944.2M | $876.9M | $834.4M | |
| Total Assets | $4.1B | $4.1B | $4.4B | $4.6B | $4.7B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.8B | $3.8B | $4B | $4.2B | $4.3B | |
| Total Equity | $387.9M | $358.6M | $354.9M | $359.1M | $401.8M | |
| Total Debt | $30M | -- | $435.1M | $310.5M | $55M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $80.8M | $41.9M | $25.7M | $17.6M | $6.4M | |
| Cash From Investing | -$325.9M | -$171.3M | -$159.7M | $10.2M | -$81.1M | |
| Cash From Financing | $218.4M | $156.1M | $114.9M | $25.7M | $32.5M | |
| Free Cash Flow | $73.8M | $32.8M | $17.3M | $16.3M | $4.9M | |
CARE
Sector
Market Cap
$415.2M
$627.9M
Price % of 52-Week High
87.89%
89.42%
Dividend Yield
0%
1.97%
Shareholder Yield
18.06%
4.06%
1-Year Price Total Return
7.43%
7.77%
Beta (5-Year)
0.766
0.585
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$18.05
200-day SMA
Buy
Level
$17.18
Bollinger Bands (100)
Buy
Level
15.3 - 17.34
Chaikin Money Flow
Buy
Level
4.2M
20-day SMA
Buy
Level
$17.56
Relative Strength Index (RSI14)
Buy
Level
59.57
ADX Line
Buy
Level
40.49
Williams %R
Neutral
Level
-41.129
50-day SMA
Buy
Level
$16.69
MACD (12, 26)
Buy
Level
0.43
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
8.2M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-2.2462)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
Stock Forecast FAQ
In the current month, CARE has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CARE average analyst price target in the past 3 months is $21.33.
-
Where Will Carter Bankshares Stock Be In 1 Year?
According to analysts, the consensus estimate is that Carter Bankshares share price will rise to $21.33 per share over the next 12 months.
-
What Do Analysts Say About Carter Bankshares?
Analysts are divided on their view about Carter Bankshares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Carter Bankshares is a Sell and believe this share price will drop from its current level to $21.00.
-
What Is Carter Bankshares's Price Target?
The price target for Carter Bankshares over the next 1-year time period is forecast to be $21.33 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CARE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Carter Bankshares is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CARE?
You can purchase shares of Carter Bankshares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Carter Bankshares shares.
-
What Is The Carter Bankshares Share Price Today?
Carter Bankshares was last trading at $18.21 per share. This represents the most recent stock quote for Carter Bankshares. Yesterday, Carter Bankshares closed at $17.93 per share.
-
How To Buy Carter Bankshares Stock Online?
In order to purchase Carter Bankshares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
